News - Powered by Yahoo NewsFDA Panel Votes Against New Use for Blood Thinner Xarelt
WEDNESDAY, May 23 (HealthDay News) -- An advisory panel to the U.S. Food and Drug Administration on Wednesday voted against a new use of a new blood thinner, Xarelto, to cut the risk of potentially lethal clots in people with acute coronary syndrome.
Wed, 23 May 2012 20:52:17 -0700 -
Senate panel votes to cut aid for Pakistan, Egyp
In a fresh warning to Pakistan, a Senate panel on Tuesday approved a foreign aid budget for next year that slashes President Barack Obama's request for assistance to Islamabad by more than half and threatens further reductions if it fails to open supply routes to NATO forces in Afghanistan.
Wed, 23 May 2012 05:35:18 -0700 -
FDA Panel Votes Against J&J And Bayer Bloodthinner For AC
In a surprise outcome, an FDA advisory panel voted 6-to-4 ? with one abstention ? against recommending the Xarelto bloodthinner for treating patients with acute coronary syndrome. Although an FDA medical reviewer raised several important issues in briefing documents released earlier this week, the agency staffer, nonetheless, recommended approval of a 2.5 mg dose because the drug has been shown ...
Wed, 23 May 2012 15:13:54 -0700 -
BCSC panel issues lifetime ban against B.C. man for frau
BCSC panel issues lifetime ban against B.C. man for fraud
Wed, 23 May 2012 12:00:00 -0700 -
China tariffs could slam U.S. solar panel firm
A move designed to punish Chinese solar panel makers that charge unfairly low prices in the United States could, ironically, end up hurting American-based solar panel installers, a fast-growing sector of the green economy.
Tue, 22 May 2012 10:00:39 -0700 -
BCSC panel cease trades unregistered Bahamian company for misconduct and refusal to provide informatio
BCSC panel cease trades unregistered Bahamian company for misconduct and refusal to provide information
Wed, 23 May 2012 10:05:00 -0700 -
Senate panel approves airline security fee hik
A Democratic-controlled Senate panel Tuesday approved a $2.50 increase in airline security fees that would double the per-passenger fee for those taking nonstop flights.
Tue, 22 May 2012 14:36:21 -0700 -
Senate panel to launch review of Facebook IP
A Senate panel is reviewing Facebook's high-profile stock offering last week amid allegations that the bank handling the IPO may have provided select clients with a negative assessment of the company.
Wed, 23 May 2012 09:58:55 -0700 -
FDA Panel Votes Against Expanded Approval Of Bayer, J&J's Xarelt
A Food and Drug Administration advisory panel narrowly voted against expanded use of Johnson & Johnson's (JNJ) and Bayer AG's (BAYRY, BAYN.XE) anticlotting drug Xarelto to treat patients with a heart problem known as acute coronary syndrome because of concerns about life-threatening bleeding.
Wed, 23 May 2012 14:21:09 -0700 -
FDA panel votes against new use for J&J's Xarelt
A majority of Food and Drug Administration panelists voted against a new use for Johnson & Johnson's blood thinner Xarelto to reduce life-threatening blood clots.
Wed, 23 May 2012 14:51:09 -0700 -